InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Thursday, 12/05/2019 7:30:25 AM

Thursday, December 05, 2019 7:30:25 AM

Post# of 767
News: $LXRX Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211

THE WOODLANDS, Texas, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced positive topline data from the Phase 1 multiple ascending dose study of LX9211, a potent oral small molecule inhibitor of adaptor associated kinase 1 (AAK1), in developm...

In case you are interested LXRX - Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LXRX News